We are live on ! Find out more
ETNB

89bio
ETNB

Delisted

ETNB was delisted on the 29th of October, 2025.

Back to rankings

34 hedge funds and large institutions have $275M invested in 89bio in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.72% more ownership

Funds ownership: 0% → 75.72% (+76%)

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$111M
2
RCM
RA Capital Management
Massachusetts
+$88M
3
VMI
VHCP Management III
New York
+$26.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
5
EAM
Eventide Asset Management
Massachusetts
+$9.74M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$25K +$26.7K +958 New
Deutsche Bank
27
Deutsche Bank
Germany
$25K +$27.4K +984 New
SO
28
STRS Ohio
Ohio
$21K +$22.3K +800 New
Bank of America
29
Bank of America
North Carolina
$17K +$17.4K +627 New
Legal & General Group
30
Legal & General Group
United Kingdom
$16K +$16.7K +601 New
Citigroup
31
Citigroup
New York
$15K +$16.4K +590 New
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$10K +$10.3K +370 New
AIP
33
Ameritas Investment Partners
Nebraska
$7K +$7.1K +255 New
Wells Fargo
34
Wells Fargo
California
$6K +$6.65K +239 New
1
2

ETNB Hedge Fund Activity: Q4 2019 in Review

34 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q4 2019, worth a combined $275M.

Buyers outnumbered sellers: 34 funds opened new ETNB positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $111M.

  • 34 institutional investors held 89bio (ETNB) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $275M of 89bio stock for Q4 2019.
  • 34 funds opened new 89bio positions in Q4 2019 and 0 closed out, a net change of +34 holders.
  • The largest 89bio buyer in Q4 2019 was OrbiMed, an estimated $111M added.

Based on aggregated 13F filings for Q4 2019.